XSXiaofeng A. Su

Xiaofeng A. Su

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaofeng A. Su has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Duanduan Ma

    BioMicro Center, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA

    2 shared publications
  • Aditi Shirke

    Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA

    1 shared publication
  • Angelika Amon

    David H. Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA

    1 shared publication
  • Charles A. Whittaker

    The Barbara K. Ostrom (1978) Bioinformatics and Computing Facility, Swanson Biotechnology Center, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA

    1 shared publication
  • Faith S. Kim

    Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA

    1 shared publication
  • James F. Amatruda

    Cancer and Blood Disease Institute, Children’s Hospital Los Angeles, Los Angeles, CA, USA

    1 shared publication

Latest Publications

  • Open Access

    Streamline CNV – A Handy Nextflow Pipeline for Chromosomal Copy Number Variation Analysis

    by Duanduan Ma, Allen Soberanes, Faith S. Kim, Aditi Shirke, Xiaofeng A. Su

    Background: Aneuploidy, characterized by imbalanced chromosomal copy number variation (CNV), occurs in both normal somatic tissues and a wide range of diseases. Low pass whole genome sequencing (LP-WGS) to detect CNVs in cells and tissues has been widely used in all biological research. Existing informatics tools for detecting CNV often require computational expertise, often posing challenges for wet-lab biologists. To address this need, we developed Streamline CNV (SLCNV) - a user-friendly and flexible copy number analysis pipeline that allows researchers to perform many copy number-related analyses steps with a single, straightforward command. Results: Streamline CNV is based on Nextflow and is packaged in a Docker image that can be executed using Singularity, making it portable and reproducible across different user environments. The pipeline automatically processes input data, performs sequencing quality control to filter problematic samples, outputs mapping statistics, CNV calling, and generates outputs including intuitive CNV plots, segmentation files (with statistics), annotation of genes on altered chromosomes, evaluation of proportion of chromosomal regions that are non-euploid. Based on user preferences, it can cluster samples solely based on CNV patterns, map the genomic location and density of genes of interest along chromosomes, and visually highlight regions with evident CNVs. In addition, it allows users to select and order chromosomes for display in plots, define sample label color palettes, and choose whether to include sample labels in the clustering visualizations. It also allows users to specify the amount of computing resources to allocate to the pipeline, such as CPU, memory, and runtime. Streamline CNV can be customizable and upgradable. It works with any species and genome assembly and efficiently supports both single-cell and bulk sequencing data with improved performance coding. Jobs can be distributed across cores of a basic Unix workstation, multiple nodes in a high-performance computing cluster using the Slurm scheduler, or cloud environments, as needed. Conclusions: We demonstrated the tool using an in-house sequencing dataset of human and mouse cell lines. Our results showed that the Streamline CNV pipeline effectively detected copy number patterns and generated informative summaries. It annotated the findings by identifying affected genes within the copy-number segments and at the break-end regions. It also reported the proportions of altered chromosomal regions impacted by copy number changes for each sample. The clustering plot demonstrated the relationships between samples based on their copy number profiles. Gene density plots aid in interpreting how genes from distinct pathways are associated with CNV pattern alterations. This tool enables researchers, regardless of bioinformatics expertise, to perform comprehensive CNV analyses across a wide range of scenarios. It also facilitates the interpretation of the copy number results and makes it possible for transforming raw CNV data into further exploration of meaningful biological insights.

  • Open Access

    RAD21 is a driver of chromosome 8 gain in Ewing sarcoma to mitigate replication stress

    by Xiaofeng A. Su, Duanduan Ma, James V. Parsons, John M. Replogle, James F. Amatruda, Charles A. Whittaker, Kimberly Stegmaier, Angelika Amon

    Aneuploidy, defined as whole-chromosome gain or loss, causes cellular stress but, paradoxically, is a frequent occurrence in cancers. Here, we investigate why ∼50% of Ewing sarcomas, driven by the EWS-FLI1 fusion oncogene, harbor chromosome 8 gains. Expression of the EWS-FLI1 fusion in primary cells causes replication stress that can result in cellular senescence. Using an evolution approach, we show that trisomy 8 mitigates EWS-FLI1-induced replication stress through gain of a copy of RAD21. Low-level ectopic expression of RAD21 is sufficient to dampen replication stress and improve proliferation in EWS-FLI1-expressing cells. Conversely, deleting one copy in trisomy 8 cells largely neutralizes the fitness benefit of chromosome 8 gain and reduces tumorgenicity of a Ewing sarcoma cancer cell line in soft agar assays. We propose that RAD21 promotes tumorigenesis through single gene copy gain. Such genes may explain some recurrent aneuploidies in cancer.